
Choose from multiple dosages




$129.00
Product Details:
Perfect For: Week 1-2 of protocol, first-time peptide users, cautious titration
Retatrutide 2mg – Pharmaceutical Grade Triple-Agonist Peptide
Begin your metabolic transformation with PeptideCarts Retatrutide 2mg, the perfect starting dosage for first-time peptide therapy users. Our pharmaceutical-grade Retatrutide activates three critical metabolic pathways—GIP, GLP-1, and glucagon receptors—delivering comprehensive weight management support backed by clinical research.
Why Choose PeptideCarts Retatrutide 2mg?
✓ Third-Party Tested Purity: Every batch undergoes independent laboratory testing, verifying 99.9%+ purity and potency
✓ Pharmaceutical Manufacturing: Produced in cGMP-certified facilities using the highest industry standards
✓ Beginner-Friendly Dosage: Ideal 2mg starting dose minimizes side effects while initiating metabolic optimization
✓ Clinical Grade Quality: Same formulation used in breakthrough clinical trials showing 24% average weight loss
✓ Complete Documentation: Certificate of Analysis included with every vial for complete transparency
How Retatrutide 2mg Works:
Retatrutide is the world’s first triple-agonist peptide, simultaneously targeting:
What’s Included:
Recommended Protocol:
Week 1-2: 2mg weekly subcutaneous injection
Perfect for: First-time peptide users, conservative dose titration, minimizing initial side effects
Storage & Handling:
Store lyophilized powder at room temperature or refrigerate. After reconstitution with bacteriostatic water, refrigerate at 2-8°C (36-46°F). Use within 28 days of reconstitution.
Quality Assurance:
Each vial is manufactured in FDA-registered, cGMP-compliant facilities and undergoes rigorous third-party testing for purity, potency, and sterility. We provide complete batch traceability and transparency.
Important Information:
Retatrutide is for research purposes only. Consult with a qualified healthcare provider before use. Not intended for human consumption without medical supervision.
| 2mg | 2mg Retatrutide per vial |
|---|





Reviews
There are no reviews yet.